Lab
Propath Services, LLC
Propath Services, LLC was paid $16.79M by Medicaid between Jan 2018 and Dec 2024, across 116 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 16% of everything it billed.
33Billing provider infoPROPATH SERVICES, LLC
DALLAS, TX 75247
DALLAS, TX 75247
33aNPI1962481820assigned 01/10/2006
33bProvider typeClinical Medical Laboratory
28Total paid$16.79M
24GClaims1,048,738
24DCodes billed116
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Texas
Rank by total paid#13 of 436
Median peer was paid$17K
This provider vs. median974×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 46,453 | $583K | |
| 2019 | 52,559 | $796K | |
| 2020 | 147,240 | $2.36M | |
| 2021 | 240,457 | $3.83M | |
| 2022 | 229,882 | $3.63M | |
| 2023 | 194,082 | $3.24M | |
| 2024incomplete | 138,065 | $2.36M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 16% | 52,623 | 41,477 | $2.71M |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 11% | 50,995 | 44,181 | $1.85M |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 9.1% | 91,420 | 88,500 | $1.53M |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 8.9% | 90,995 | 88,093 | $1.50M |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 7.7% | 87,643 | 85,960 | $1.30M |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 6.1% | 70,097 | 67,721 | $1.03M |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 4.7% | 53,328 | 52,258 | $781K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3.9% | 9,925 | 9,189 | $647K |
| 87481 | 3.1% | 46,382 | 41,964 | $515K | |
| 80081 | 2.9% | 11,573 | 11,353 | $491K | |
| 87511 | 2.6% | 40,050 | 38,839 | $432K | |
| 88342 | 2.4% | 10,530 | 9,535 | $406K |
104 more codes
| 88312 | 2.0% | 5,186 | $339K | |
| 87653 | 1.8% | 19,610 | $299K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1.8% | 21,102 | $295K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.3% | 7,698 | $226K |
| 88141 | 1.3% | 15,313 | $210K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 27,143 | $134K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 26,628 | $127K |
| 88341 | <1% | 2,600 | $112K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 5,891 | $106K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 13,695 | $105K |
| 86803 | <1% | 14,857 | $98K | |
| 87625 | <1% | 5,840 | $97K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 11,587 | $97K |
| 86696 | <1% | 8,209 | $88K | |
| 88304 | <1% | 3,864 | $82K | |
| 88313 | <1% | 1,786 | $71K | |
| 84702 | <1% | 9,558 | $65K | |
| 82105 | <1% | 6,682 | $63K | |
| 88142 | <1% | 4,825 | $59K | |
| 80053 | Comprehensive metabolic panel | <1% | 8,251 | $54K |
| 86592 | <1% | 20,269 | $49K | |
| 87340 | <1% | 8,496 | $46K | |
| 80074 | <1% | 2,216 | $44K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 3,995 | $43K |
| 87529 | <1% | 3,868 | $42K | |
| 80050 | General health panel | <1% | 1,833 | $40K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 8,639 | $39K |
| 82950 | <1% | 12,443 | $36K | |
| 87563 | <1% | 3,297 | $35K | |
| 86850 | <1% | 5,585 | $28K | |
| 86695 | <1% | 4,249 | $27K | |
| 87077 | <1% | 5,725 | $26K | |
| 82951 | <1% | 3,650 | $26K | |
| 84144 | <1% | 1,590 | $22K | |
| 84403 | <1% | 1,551 | $21K | |
| 87186 | <1% | 4,305 | $21K | |
| 83001 | <1% | 2,127 | $21K | |
| 86787 | <1% | 2,486 | $20K | |
| 80061 | Lipid panel | <1% | 3,155 | $17K |
| 82670 | <1% | 1,038 | $17K | |
| 84146 | <1% | 1,592 | $17K | |
| 83020 | <1% | 1,891 | $16K | |
| 84439 | <1% | 4,057 | $16K | |
| 86762 | <1% | 1,518 | $14K | |
| 83002 | <1% | 1,391 | $14K | |
| 81001 | <1% | 7,477 | $13K | |
| 86780 | <1% | 1,445 | $11K | |
| 85027 | <1% | 2,379 | $10K | |
| 84270 | <1% | 876 | $9K | |
| 86901 | <1% | 3,698 | $8K | |
| 88112 | <1% | 331 | $8K | |
| 85660 | <1% | 2,291 | $8K | |
| 86900 | <1% | 3,712 | $7K | |
| 82952 | <1% | 2,642 | $6K | |
| 87147 | <1% | 2,172 | $6K | |
| 82607 | <1% | 1,525 | $6K | |
| 87184 | <1% | 1,224 | $6K | |
| 86706 | <1% | 758 | $5K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 25 | $5K |
| 84156 | <1% | 2,279 | $5K | |
| 87070 | <1% | 1,004 | $5K | |
| 82570 | <1% | 1,442 | $4K | |
| 82627 | <1% | 370 | $4K | |
| 80055 | <1% | 212 | $4K | |
| 82746 | <1% | 1,201 | $4K | |
| 84481 | <1% | 485 | $4K | |
| 88307 | <1% | 39 | $4K | |
| 88189 | <1% | 140 | $3K | |
| 82728 | <1% | 383 | $3K | |
| 86694 | <1% | 373 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 58,849 | $2K |
| 82657 | <1% | 128 | $2K | |
| 82677 | <1% | 92 | $1K | |
| 84550 | <1% | 440 | $1K | |
| 88365 | <1% | 13 | $1K | |
| 84436 | <1% | 532 | $1K | |
| 83540 | <1% | 298 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 182 | $1K |
| 81329 | <1% | 28 | $941.19 | |
| 83550 | <1% | 171 | $906.16 | |
| 88360 | <1% | 38 | $857.64 | |
| 86336 | <1% | 92 | $849.83 | |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | <1% | 30 | $824.91 |
| 88377 | <1% | 30 | $809.98 | |
| 84479 | <1% | 447 | $782.55 | |
| 82397 | <1% | 112 | $554.75 | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 1,150 | $521.01 |
| 82465 | <1% | 169 | $477.00 | |
| 82166 | <1% | 25 | $389.28 | |
| 86769 | <1% | 19 | $380.59 | |
| 83525 | <1% | 60 | $328.14 | |
| 87075 | <1% | 52 | $315.98 | |
| 88302 | <1% | 15 | $261.63 | |
| 82565 | <1% | 61 | $198.96 | |
| 86376 | <1% | 24 | $147.73 | |
| 87081 | <1% | 39 | $115.69 | |
| 86593 | <1% | 39 | $77.99 | |
| 86886 | <1% | 25 | $63.89 | |
| 86800 | <1% | 12 | $57.24 | |
| 83615 | <1% | 14 | $46.64 | |
| 88323 | 0% | 12 | $0.00 | |
| 85007 | 0% | 30 | $0.00 | |
| 0753T | 0% | 160 | $0.00 | |
| 0760T | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialVALLADARES, DINA (SR DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Memphis Pathology Laboratory | Memphis, TN | $61.43M |
| Seacoast Pathology INC | Exeter, NH | $995K |
| Pinkus Dermatopathology Laboratory, PC | Monroe, MI | $816K |
| Bernhardt Laboratories INC | Jacksonville, FL | $620K |
| Cleveland Skin Pathology Laboratory, INC | Beachwood, OH | $609K |
| Carla B. Macleod M.D. & Associates LLC | Gaithersburg, MD | $292K |
| Biopsy Diagnostics, LLC | Ridgeland, SC | $255K |
| Pinkus Dermatopathology Laboratory, PC | Monroe, MI | $93K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.